Clinical Trial Update: Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing an enteroadsorbent (polymethylsiloxane) vs a probiotic (Lactobacillus reuteri) for rotaviral gastroenteritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Enteroadsorbent polymethylsiloxane (polymethylsiloxane)
• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: University Hospital for Infectious Diseases, Croatia | Conditions: Rotavirus Gastroenteritis | Phase 4 | Status: COMPLETED